Srsf1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Srsf1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
```{.infobox .infobox-protein} ```
Overview
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions. [@liu2019]
Structure
SRSF1 contains two RNA recognition motifs (RRMs) at its N-terminus, connected by a hinge region, followed by an C-terminal RS domain (arginine/serine-rich) that is extensively phosphorylated. The RRMs bind to exonic splicing enhancers (ESEs) in pre-mRNA, while the RS domain mediates protein-protein interactions with other splicing factors and components of the spliceosome. [@izumi2021]
Key Structural Features
RRM1 and RRM2 — Two highly conserved RNA recognition motifs that bind to short RNA sequences
RS Domain — C-terminal serine/arginine-rich domain subject to extensive phosphorylation by SR protein kinases (SRPK1, CLK1)
SRSF1 is a prototypical SR protein that functions as an essential splicing factor: [@boutz2007]
Alternative splicing regulation — Recognizes and binds to exonic splicing enhancers to promote inclusion of alternative exons
Spliceosome recruitment — Facilitates assembly of the spliceosome machinery
mRNA quality control — Participates in nonsense-mediated decay (NMD) by regulating splicing of NMD factors
Transcriptional co-activation — Can function as a co-activator for transcription
Role in Disease
Amyotrophic Lateral Sclerosis (ALS)
Splicing dysregulation — Loss of normal SRSF1 function leads to aberrant splicing patterns
Interaction with ALS proteins — SRSF1 interacts with [TDP-43](/mechanisms/tdp-43-proteinopathy) and FUS, which are mutated in familial ALS
Stress granule dynamics — SRSF1 localizes to stress granules under cellular stress
Cancer
Oncogenic function — SRSF1 is overexpressed in many cancers and promotes tumorigenesis
Splicing of oncogenic transcripts — Alters splicing of transcripts involved in cell proliferation and survival
Therapeutic Targeting
SRPK inhibitors — Small molecule inhibitors targeting SR protein kinases (e.g., SRPK1) can modulate SRSF1 phosphorylation and function
Antisense oligonucleotides — ASOs targeting SRSF1 splicing activity are being explored
Research compounds — TG003 and others target CLK family kinases that phosphorylate SRSF1
Key Publications
[Singh et al., Structural basis for SRSF1 function (2015)](https://doi.org/10.1016/j.tibs.2015.08.005)
[Zhou et al., SRSF1 in neurodegeneration (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.05.020)
[Bourbon et al., SR protein kinases as therapeutic targets (2020)](https://doi.org/10.1038/s41573-020-0087-3)
Cross-links
[SRSF1 gene](/genes/srsf1) — Gene encoding this protein
[TDP-43](/proteins/tdp-43-protein) — ALS-linked protein
[FUS](/proteins/fus-protein) — ALS-linked protein
[SRPK1](/genes/srpk1) — Kinase that phosphorylates SRSF1
Background
The study of Srsf1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@krainer2001]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@black2003]